Signos raised $20 million for its approach to using continuous glucose monitors to help people lose weight. And Oura unveiled today its latest, smallest ring.
We have two pieces of wearables-related news for you today, and (maybe unsurprisingly) GLP-1s came up in our conversations with both companies.
First, Signos
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking
Signos raises $20M, expands Dexcom partnership for weight loss
Oura compra Galen AI e leva o anel inteligente para a saúde conectada – CartaCapital
Why Noninvasive Blood Glucose Monitoring Is Still the Holy Grail of Wearables
Samsung, Mass General study Galaxy Watch for GLP-1 patients
Oura brings rings to the cuffless blood pressure party
Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
I’ve worn the $99 Fitbit Air and $349 Oura Ring 4 to track my sleep for a week — here's the winner
Samsung has a ring. Apple is rumoured to have one. Finland's Oura just filed for IPO and made its smart ring 40% smaller — TFN
I dug deeper into my Oura Ring data using this free app - here's what I found
Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical device…
Signos, a startup that aims to help people lose weight by understanding their blood sugar, has raised a new $20 million round of…
Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, from…
Google Ventures, Dexcom, and Blue Cross Blue Shield of Alabama backed the round as demand for weight loss tools grows
Structure Therapeutics CEO Ray Stevens talked about the biotech’s path forward and his expectations for the future of the booming…
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward…
